Argeloside B - Compound Card

Argeloside B

Select a section from the left sidebar

Argeloside B

Structure
Zoomed Structure
  • Family: Plantae - Apocynaceae
  • Kingdom: Plantae
  • Class: Steroid
    • Subclass: Pregnane Glycoside
Canonical Smiles CO[C@@H]1C[C@@H](OC([C@H]1O[C@H]1C[C@@H](O)[C@@H](C(O1)C)O[C@H]1C[C@@H](O)[C@@H](C(O1)C)O[C@H]1C[C@@H](OC)[C@@H](C(O1)C)O[C@@H]1OC(CO)[C@H]([C@@H](C1O)O)O)C)O[C@H]1[C@H](OC)C[C@@H](OC1C)O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@@]43O[C@H]3[C@@H]2[C@](O4)(C)OC3)C)C1)COC(=O)C
InChI InChI=1S/C62H98O26/c1-27-52(82-44-19-37(65)53(28(2)75-44)83-47-23-41(72-11)56(31(5)79-47)86-58-51(69)50(68)49(67)42(24-63)81-58)38(66)20-45(76-27)84-54-30(4)78-48(22-40(54)71-10)85-55-29(3)77-46(21-39(55)70-9)80-34-14-17-61(26-73-32(6)64)33(18-34)12-13-36-35(61)15-16-59(7)57-43-25-74-60(57,8)88-62(36,59)87-43/h12,27-31,34-58,63,65-69H,13-26H2,1-11H3/t27?,28?,29?,30?,31?,34-,35-,36+,37+,38+,39+,40+,41+,42?,43+,44-,45-,46-,47-,48-,49+,50-,51?,52+,53+,54+,55+,56+,57-,58-,59+,60+,61+,62-/m0/s1
InChIKey FNHGVUUMWYKAFF-LNAHLQCFSA-N
Formula C62H98O26
HBA 26
HBD 6
MW 1259.44
Rotatable Bonds 18
TPSA 313.82
LogP 2.12
Number Rings 12
Number Aromatic Rings 0
Heavy Atom Count 88
Formal Charge 0
Fraction CSP3 0.95
Exact Mass 1258.63
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Solenostemma argel Apocynaceae Plantae 219273
2 Solenostemma argel Apocynaceae Plantae 219273

Showing of synonyms

  • Plaza A, Bifulco G, et al. (2003). Argeloside A and B, two novel 14,15-secopregnane glycosides from Solenostemma argel. Tetrahedron Letters,2003,44(47),8553-8558. [View]
  • Plaza A, Perrone A, et al. (2005). New antiproliferative 14,15-secopregnane glycosides from Solenostemma argel. Tetrahedron,2005,61(31),7470-7480. [View]
Pubchem: 162955994
Nmrshiftdb2: 60048176

No compound-protein relationship available.

Structure

SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC(OC9)CCC9OC(OC1)CCC1OC(OC1)CCC1OC1CCCCO1

Level: 6

Mol. Weight: 1259.44 g/mol

Structure

SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC(OC9)CCC9OC(OC1)CCC1OC1CCCCO1

Level: 5

Mol. Weight: 1259.44 g/mol

Structure

SMILES: C1OCCCC1OC(OC2)CCC2OC(OC3)CCC3OC(OC4)CCC4OC(OC5)CCC5OC6CCCCO6

Level: 5

Mol. Weight: 1259.44 g/mol

Structure

SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC(OC9)CCC9OC1CCCCO1

Level: 4

Mol. Weight: 1259.44 g/mol

Structure

SMILES: O1CCCCC1OC2CCC(OC2)OC3CCC(OC3)OC4CCC(OC4)OC5CCCOC5

Level: 4

Mol. Weight: 1259.44 g/mol

Structure

SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC9CCCCO9

Level: 3

Mol. Weight: 1259.44 g/mol

Structure

SMILES: C1OCCCC1OC(OC2)CCC2OC(OC3)CCC3OC4CCCCO4

Level: 3

Mol. Weight: 1259.44 g/mol

Structure

SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC8CCCCO8

Level: 2

Mol. Weight: 1259.44 g/mol

Structure

SMILES: O1CCCCC1OC2CCC(OC2)OC3CCCOC3

Level: 2

Mol. Weight: 1259.44 g/mol

Structure

SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC7CCCCO7

Level: 1

Mol. Weight: 1259.44 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1259.44 g/mol

Structure

SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCCC6

Level: 0

Mol. Weight: 1259.44 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1259.44 g/mol

Antiproliferative

Absorption

Caco-2 (logPapp)
-6.38
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
4678275208265.360
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
611395281524601.4

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.470
Plasma Protein Binding
86.05
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
2.970
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-14219670970646.369
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-5806060.770
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.050
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-1109652917034877952.000
Rat (Acute)
826.240
Rat (Chronic Oral)
2380108496.110
Fathead Minnow
1400699776705282.250
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
124805202651881792.000
Hydration Free Energy
-2.920
Log(D) at pH=7.4
-69379234290.860
Log(P)
-8076558.69
Log S
-4.94
Log(Vapor Pressure)
-4109771660856916.5
Melting Point
-1248809502.22
pKa Acid
-29946165497288.6
pKa Basic
-240916042845.67
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Probable NDP-rhamnosyltransferase Q9ALM8 Q9ALM8_SACSN Saccharopolyspora spinosa 3 0.7942
Probable NDP-rhamnosyltransferase Q9ALM8 Q9ALM8_SACSN Saccharopolyspora spinosa 3 0.7942

Download SDF